BUDESONIDE/ FORMOTEROL (Symbicort Turbohaler®)

Clinical Indication

Asthma

Date of classification

May 2026

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.